Study assesses the impact of mindfulness on anxiety and depression in Parkinson’s disease


Author: Sarah McGrathPublished: 23 February 2023

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A woman sitting on a white sofa sitting crossed legged with her eyes closed

Researchers in Hong Kong have assessed the impact of mindfulness meditation on levels of anxiety and depression in people with Parkinson’s compared with that of stretching and resistance training exercise (SRTE).

The small study involved 68 people with Parkinson’s who were randomly assigned to take part in either a mindfulness programme or an SRTE programme over the course of eight weeks. The mindfulness programme involved meditation sessions, while the SRTE programme focused on full-body exercise sessions.

Participants in the mindfulness programme showed decreased symptoms of depression immediately after the programme, while the symptoms of those in the SRTE group remained level. However, no significant changes were identified between the two groups after three months. Furthermore, no differences in anxiety levels were identified in either group or between the two groups.

“These findings suggest that mindfulness meditation might be a promising complementary lifestyle practice for… managing depressive mood among [people] with Parkinson’s,” the researchers concluded.

Read more:

Altered speech might be an early symptom of Parkinson’s disease

Could a sea sponge support the search for Parkinson’s disease treatments?

Go Back

Share this story


Related articles

A rear view of Dr Indu Subramanian doing a yoga pose in a sunny field

Health & Fitness

Mobility, mindfulness and mood: exploring the potential benefits of yoga

Dr Indu Subramanian on a “holistic” approach to Parkinson’s disease


Special reports

Ask the expert: Parkinson’s disease and mental health

Professor Dr Bernd Leplow on why communication about symptoms is crucial



“There is something marvellous about taking control of our lives”

Jo Yaldren on her ‘Year of Yes’ with Parkinson’s disease